Sample results
Graft-versus-host disease (GVHD) is a serious complication that occurs after bone marrow or stem cell transplantation when donor immune cells attack the recipient's healthy tissues. It is caused by donor T-lymphocytes recognizing the recipient's body as foreign and mounting an immune response against organs like the skin, liver, and gastrointestinal tract. The Immune Cell Function test is the most important test for monitoring GVHD because it evaluates immune cell activity and helps healthcare providers assess disease severity and treatment response.
Graft-versus-host disease is caused by donor T-lymphocytes and other immune cells from transplanted bone marrow or stem cells attacking the recipient's body tissues. After transplantation, these donor immune cells recognize the recipient's organs and tissues as foreign, triggering an immune response that damages healthy cells. The severity depends on factors like the degree of tissue matching between donor and recipient, the type of transplant conditioning regimen used, and the effectiveness of immunosuppressive medications given to prevent this complication.
The Immune Cell Function test is the most important blood test for monitoring GVHD because it evaluates how transplanted immune cells are functioning and whether they are causing abnormal immune activity against the recipient's tissues. This comprehensive test measures immune cell populations, their activation status, and their functional capacity, providing critical information about disease severity and treatment effectiveness. While GVHD is primarily diagnosed through clinical symptoms and tissue biopsies, regular blood testing of immune cell function helps healthcare providers adjust immunosuppressive medications, predict flare-ups, and detect complications early before they become severe.
You should get tested if you have recently undergone a bone marrow or stem cell transplant and develop symptoms like skin rashes, persistent diarrhea, yellowing of the skin or eyes, or unexplained weight loss. Regular blood testing should begin immediately after transplantation and continue throughout the first year when GVHD risk is highest. You should also seek testing if you notice new symptoms developing months or years after transplant, as chronic GVHD can emerge later, or if your healthcare provider needs to adjust your immunosuppressive medications based on your immune function status.
What this means
Your immune cell function is below the optimal range, indicating your immune system is significantly suppressed. This is common in transplant patients on immunosuppressive medications, but at this level you may have an increased risk of infections. Your transplant team should review your medication dosage to find the right balance between preventing rejection and maintaining adequate immune defense.
Recommended actions
Contact your transplant team to discuss your results and potential medication adjustments
Practice strict infection prevention: frequent handwashing, avoid sick contacts, and stay current on vaccines your doctor approves
Maintain a nutrient-rich diet with adequate protein to support overall health
Retest as recommended by your transplant specialist, typically within 4-8 weeks after any medication changes
Not overhyped or overpriced. Just comprehensive blood testing made simple and for everyone.
Sample results
Your 24/7 Personal Lab Guide
Quick questions: